Epidemiology and Treatment of Chronic Kidney Disease among Commercially-Insured Patients in the U.S

被引:0
|
作者
Kauf, Teresa
Wang, Weiying
Dillon, Allison
Singh, Inderjit
Odegard, John T.
Ringemann, Christian
Haldrup, Steffen
机构
关键词
D O I
10.2337/db20-1515-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1515-P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Epidemiology and treatment of chronic kidney disease among commercially-insured patients in the US
    Kauf, T.
    Wang, W.
    Dillon, A.
    Mikulski, H.
    Singh, I.
    Odegard, J.
    Ringemann, C.
    Haldrup, S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S143 - S143
  • [2] Patterns and Predictors of Rotavirus Vaccine Use among Commercially-Insured U.S: Infants
    Panozzo, Catherine A.
    Brookhart, M. Alan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 360 - 360
  • [3] Longitudinal Treatment Pathways Following Opioid Use Disorder Diagnosis Among Commercially-Insured Beneficiaries in the U.S
    Rizk, John G.
    Pathan, Uzma
    Saini, Jannat
    DiPaula, Bethany
    Ehret, Megan
    Johnson, Abree
    Qato, Danya M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 16 - 17
  • [4] Burden of illness among patients with Alzheimer's disease in a commercially-insured population
    Zhao, Y
    Bowman, L
    Flynn, JA
    Joyce, AT
    Carter, CT
    Ollendorf, DA
    VALUE IN HEALTH, 2006, 9 (03) : A68 - A69
  • [5] Real-World Flare Rates and Progression by Treatment Settings Among the Commercially-Insured Systemic Lupus Erythematosus Population in the U.S
    Wu, Sandra Sze-Jung
    Perry, Allison
    Varker, Helen
    Bizier, Richard
    Tkacz, Joseph
    Ortmann, Robert
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 257 - 259
  • [6] THE BURDEN OF OPIOID ABUSE AMONG COMMERCIALLY-INSURED PATIENTS
    Rice, J. B.
    Kirson, N. Y.
    Shei, A.
    Enloe, C.
    Cummings, A. K.
    Birnbaum, H. G.
    Ben-Joseph, R.
    VALUE IN HEALTH, 2014, 17 (03) : A214 - A214
  • [7] Unmet Treatment Needs Among Commercially Insured Patients With Irritable Bowel Syndrome With Constipation (IBS-C) or Chronic Constipation (CC) in the U.S
    Stephenson, Judith
    Buono, Jessica
    Spalding, William
    Cai, Qian
    Tan, Hiangkiat
    Carson, Robyn
    Doshi, Jalpa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S643 - S643
  • [8] ANALYSIS OF DULOXETINE UTILIZATION AMONG COMMERCIALLY-INSURED FIBROMYALGIA PATIENTS
    Chen, S. Y.
    Wu, N.
    Boulanger, L.
    Rao, P.
    Peng, X.
    Zhao, Y.
    VALUE IN HEALTH, 2010, 13 (03) : A143 - A143
  • [9] Use of chronic medications among a large, commercially-insured US population
    Roe, CM
    McNamara, AM
    Motheral, BR
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (04) : 301 - 309
  • [10] PREVALENCE OF HEPATIC OUTCOMES AMONG COMMERCIALLY-INSURED PATIENTS DIAGNOSED WITH CHRONIC HEPATITIS C VIRUS
    Scaife, J.
    Kuti, E.
    Acampa, L.
    Million, R.
    Miyasato, G.
    Wang, Z.
    Sander, S.
    Sanchez, H.
    Kokkotos, F. K.
    VALUE IN HEALTH, 2013, 16 (03) : A82 - A82